低眼压青光眼中黄斑神经节细胞-内丛状层丢失先于视盘周围视网膜神经纤维层丢失
这项前瞻性纵向队列研究纳入207例(271眼)有统计学显著青光眼进展证据的患者,比较mGCIPL与pRNFL最早出现结构进展的影响因素。结果显示预处理最大眼压、基线pRNFL厚度、基线mGCIPL厚度及系统性高血压与首次进展部位相关;mGCIPL先进展者预处理眼压更低,且更易出现旁中心视野缺损。
要点
- mGCIPL先进展者预处理最大眼压显著低于pRNFL先进展者,平均差3.90 mmHg。
- 眼压每升高5 mmHg,pRNFL与mGCIPL进展间隔增加12.4个月。
- mGCIPL先进展者新发旁中心视野缺损风险是pRNFL先进展者的3.03倍。
核心结论
- 临床特征尤其预处理眼压影响青光眼结构进展更早被mGCIPL还是pRNFL成像检出。
- 数据支持在pRNFL分析之外加用mGCIPL成像检测青光眼进展,尤其正常眼压患者。
研究设计与样本
- 前瞻性纵向队列研究,从686例(1271眼)疑似青光眼或早期青光眼监测者中纳入207例(271眼)OCT GPA显示统计学显著进展证据的眼。
- 比较mGCIPL GPA事件分析最早进展者与pRNFL GPA事件分析最早进展者。
主要发现
- mGCIPL最早进展眼的最大记录预处理眼压显著更低,平均差3.90 mmHg(95%CI 2.37-5.43,P<0.001)。
- 眼压每增加5 mmHg,pRNFL与mGCIPL进展间隔增加12.4个月(95%CI 10.32-15.72个月)。
- mGCIPL最早进展眼基线平均pRNFL厚度显著低于pRNFL先进展眼,平均差7.07 μm(95%CI 4.38-9.77,P<0.001)。
- mGCIPL参数先进展眼出现新旁中心视野缺损的可能性是pRNFL参数先进展眼的3.03倍(OR 3.03,95%CI 1.26-7.28,P=0.01)。
关键数值与推荐
- 眼压、基线pRNFL厚度、基线mGCIPL厚度及系统性高血压与首次进展部位相关。
临床怎么用
- 对低眼压青光眼患者,除pRNFL外应加用mGCIPL成像以更早检出结构进展。
- mGCIPL先进展提示需关注旁中心视野缺损风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate which clinical measures influence whether an individual demonstrates earliest glaucomatous structural progression on peripapillary retinal nerve fiber layer (pRNFL) or macular ganglion cell-inner plexiform layer (mGCIPL). DESIGN: Prospective, longitudinal cohort study. PARTICIPANTS: Two hundred seventy-one eyes from 207 individuals with statistically significant evidence of glaucomatous progression on OCT Guided Progression Analysis (GPA) software were drawn from a total of 1271 eyes from 686 individuals categorized as glaucoma suspect or having early manifest glaucoma undergoing glaucoma surveillance. METHODS: Individuals demonstrating earliest evidence of longitudinal progression on mGCIPL GPA event analysis were compared with individuals demonstrating evidence of earliest longitudinal progression on pRNFL GPA event analysis. MAIN OUTCOME MEASURES: Correlation of OCT event change analysis with intraocular pressure (IOP), clinical variables, and baseline thickness of the pRNFL and mGCIPL. RESULTS: Intraocular pressure, baseline pRNFL thickness, baseline mGCIPL thickness, and systemic hypertension were associated with location of first progression. Eyes demonstrating earliest longitudinal progression on mGCIPL had significantly lower maximum-recorded pretreatment IOP (mean difference, 3.90 mmHg; 95% confidence interval [CI], 2.37-5.43 mmHg; P < 0.001). The interval between progression on pRNFL and progression on mGCIPL increased by 12.4 months for every 5-mmHg increase in IOP (95% CI, 10.32-15.72 months). Eyes demonstrating earliest longitudinal progression on mGCIPL showed significantly lower baseline average pRNFL thickness than eyes progressing on pRNFL first (mean difference, 7.07 μm; 95% CI, 4.38-9.77 μm; P < 0.001). Eyes progressing first on mGCIPL parameters were 3.03 times more likely to demonstrate a new paracentral field defect than eyes progressing first on pRNFL parameters (odds ratio, 3.03; 95% CI, 1.26-7.28; P = 0.01). CONCLUSIONS: Clinical features, particularly pretreatment IOP, influence whether structural glaucoma progression is detected earlier with mGCIPL or pRNFL imaging. These data support the usefulness of mGCIPL imaging in addition to pRNFL analysis for detection of glaucoma progression, particularly in patients with normal IOP.
引用
- Marshall HN, Andrew NH, Hassall M, et al. Macular Ganglion Cell-Inner Plexiform Layer Loss Precedes Peripapillary Retinal Nerve Fiber Layer Loss in Glaucoma with Lower Intraocular Pressure. Ophthalmology. 2019. PMID: 30910584. doi:10.1016/j.ophtha.2019.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。